![Suk-Hyung Kwon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suk-Hyung Kwon
Directeur Général chez
NOVAREX CO.,LTD.
Fortune : 19 M $ au 31/08/2026
Profil
Dr. Suk-Hyung Kwon is a Chief Executive Officer at NOVAKMED, a Chairman at Korea Health Supplements Association and a Chairman & Co-Chief Executive Officer at NOVAREX Co., Ltd. Dr. Kwon was previously employed as a Senior Associate by STIC Investments, Inc. He also served on the board at Rexahn Pharmaceuticals, Inc. He received his doctorate degree from Chung-Ang University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVAREX CO., LTD. 12,5% | 27/08/2026 | 2 344 214 ( 12,5% ) | 19 M $ | 31/08/2026 |
Postes actifs de Suk-Hyung Kwon
| Sociétés | Poste | Début |
|---|---|---|
| NOVAREX CO.,LTD. | Directeur Général | 22/03/2019 |
NOVAKMED | Directeur Général | 02/01/2017 |
Korea Health Supplements Association | Président | 25/02/2016 |
Anciens postes connus de Suk-Hyung Kwon
| Sociétés | Poste | Fin |
|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/06/2005 |
STIC Investments, Inc. (South Korea)
 STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC invests in small, middle and large market companies located in Korea, Southeast Asia, Middle East, and Europe. The firm targets companies operating in the fields of industrials & business services, ICT, bio & healthcare, consumer & consumer technology, and games & entertainment sectors. It provides financing for buyout and growth transactions. | Analyste en capital-investissement | - |
Formation de Suk-Hyung Kwon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
STIC Investments, Inc. (South Korea)
STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC invests in small, middle and large market companies located in Korea, Southeast Asia, Middle East, and Europe. The firm targets companies operating in the fields of industrials & business services, ICT, bio & healthcare, consumer & consumer technology, and games & entertainment sectors. It provides financing for buyout and growth transactions. | Finance |
Chung-Ang University
 Chung-Ang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NOVAREX Co., Ltd.
 NOVAREX Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops and manufactures functional ingredients and food dietary supplements | Health Technology |
Korea Health Supplements Association | |
NOVAKMED |
